DPP4 and inflammatory bowel disease: CD26 levels have been shown to correlate with disease severity in chronic inflammatory and autoimmune diseases such as RA, IBD, multiple sclerosis, and Graves’ disease, suggesting a role for CD26+ T cells in mediating inflammation and tissue damage.